Home » AstraZeneca's Breast Cancer Drug Gets 6-Month Extension
AstraZeneca's Breast Cancer Drug Gets 6-Month Extension
AstraZeneca said the U.S. Food and Drug Administration has granted a six-month extension to the exclusivity patent for the marketing of its breast cancer drug Arimidex.
Hemscott
Hemscott
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May